Maureen Donovan, PhD, received an award from the National Institute for Pharmaceutical Technology and Education (NIPTE) as part of an FDA U01 project.  Her proposal “Pediatric Nasal Dosage Forms: In Vitro Characterization of Intranasal Deposition Patterns in Children for Optimal Delivery and Performance” was chosen by the FDA in the Open Proposals review area.